When production and quality teams operate independently, compliance risks increase across manufacturing operations. Disconnected systems make it difficult to maintain accurate visibility into part status and movement on the shop floor.

This separation often leads to situations where digital systems indicate that a part is in quarantine, while it is physically being moved or used in production. Such misalignment creates serious exposure during regulatory reviews and inspections.

This article explains how the risks of siloed organizational structure can directly contribute to FDA inspection failures. When data is fragmented, organizations struggle to demonstrate consistent control between documented processes and real-world activity.

LocaXion shows how a unified Digital Twin approach brings production and quality teams together under a single source of truth. By aligning physical and digital data, manufacturers can reduce compliance risk and maintain operational integrity.